Faeth Therapeutics, Inc. SEC filings FTH
Faeth Therapeutics, Inc. has 452 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 12, 2026 | — |
| D | Filing | Mar 4, 2026 | — |
| 8-A12B | Filing | Mar 7, 2023 | — |
| EFFECT | Filing | May 9, 2022 | — |
| CORRESP | Letter to the SEC | May 6, 2022 | — |
| CORRESP | Letter to the SEC | May 6, 2022 | — |
| CORRESP | Letter to the SEC | May 4, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2022 | — |
| EFFECT | Filing | Feb 3, 2021 | — |
| CERT | 8a cert | Feb 3, 2021 | — |
| 8-A12B | Filing | Feb 2, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| CORRESP | Letter to the SEC | Jan 22, 2021 | — |
| CORRESP | Letter to the SEC | Jan 15, 2021 | — |
| SEC STAFF LETTER | Filing | Dec 29, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 29, 2020 | — |
| DRSLTR | Filing | Dec 22, 2020 | — |
| DRS/A | Filing | Dec 22, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2020 | — |
| DRS | Filing | Nov 12, 2020 | — |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829802
- Former names
- Sensei Biotherapeutics, Inc. (until Jun 16, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.